| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |